Comparison Between Ultrasonographic Cervical Length and Bishop Score in Preinduction Cervical Assessment
1 other identifier
interventional
154
1 country
1
Brief Summary
To compare the ultrasonographic cervical length with the Bishop score in determining the administration of prostaglandin for preinduction cervical ripening in nulliparas at term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 16, 2011
CompletedFirst Posted
Study publicly available on registry
March 17, 2011
CompletedMarch 17, 2011
March 1, 2011
1.7 years
March 16, 2011
March 16, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Successful labor induction
Induction success was defined as an ability to achieve the active phase of labor corresponding to a cervical dilatation of ≥ 4 cm within 11 hours of initiating oxytocin (i.e., within 22 hours of the administration of a dinoprostone vaginal insert) on the first day of induction.
Eleven hours of initiating oxytocin on the fist day of induction
Secondary Outcomes (1)
the need for oxytocin induction
After removing prostaglandin, the following day when an intravenous oxytocin infusion was started
Study Arms (2)
Bishop score
ACTIVE COMPARATORtransvaginal ultrasound
ACTIVE COMPARATORInterventions
Assessment of cervical status based on Bishop score versus sonographically measured cervical length
Eligibility Criteria
You may qualify if:
- nulliparous patients
- singleton pregnancy
- live fetus with vertex presentation
- intact amniotic membranes
- \> 37 weeks gestation
- absence of labor
- no previous uterine surgical procedures
You may not qualify if:
- major congenital anomaly
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Obstetrics and Gynecology Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Kyo Hoon Park, MD, PhD
Seoul National University Bundang Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 16, 2011
First Posted
March 17, 2011
Study Start
November 1, 2008
Primary Completion
August 1, 2010
Study Completion
August 1, 2010
Last Updated
March 17, 2011
Record last verified: 2011-03